Locations:
Search
Peter Clardy, M.D., director of the Clinical Enterprise Team at Google Health, provided the keynote address
Results suggest one shot could keep Lipoprotein(a) levels lower for nearly a year
One-time infusion of investigational CRISPR-Cas9 therapy found to safely reduce LDL cholesterol by 52.5% and triglycerides by 47.8% 12 months after initial treatment
Health system is among only a handful in the U.S. to offer the minimally invasive robotic procedure
Innovation, treatments and breakthrough research told through the eyes of inspiring patients and doctors.
Services include fulfilling requests for live, remote and pre-recorded interviews, as well as providing a range of assets such as infographics, photos and b-roll footage.